All lobbying filings

MEHLMAN CONSULTING, INC.

Lobbying for ASSOCIATION OF ACCESSIBLE MEDICINES · Trade Association

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 3

S 1040
Drug Competition Enhancement Act
S 1954
Biosimilar Red Tape Elimination Act
HR 3269
ETHIC Act

Lobbying activity 3

Medicare/Medicaid

Issues related to generic medicines.

Health Issues

Issues related to generic medicines. issues related to generic and biosimilar medications.

Pharmacy

Issues related to pharmaceutical manufacturing supply chain. S. 1040 - Drug Competition Enhancement Act. S. 1954 - Biosimilar Red Tape Elimination Act. H.R. 3269 - ETHIC Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.